Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ferroptosis in hepatocellular carcinoma: from bench to bedside
Daolin Tang, Guido Kroemer, Rui Kang
Hepatology (2023) Vol. 80, Iss. 3, pp. 721-739
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

GPX4 in cell death, autophagy, and disease
Yangchun Xie, Rui Kang, Daniel J. Klionsky, et al.
Autophagy (2023) Vol. 19, Iss. 10, pp. 2621-2638
Open Access | Times Cited: 225
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 145
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 51
ATF4 in cellular stress, ferroptosis, and cancer
Hu Tang, Rui Kang, Jiao Liu, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 4, pp. 1025-1041
Closed Access | Times Cited: 26
Mechanisms of alkaliptosis
Fangquan Chen, Rui Kang, Jiao Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Targeting paraptosis in cancer: opportunities and challenges
Fangquan Chen, Hu Tang, Xiutao Cai, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 3, pp. 349-363
Open Access | Times Cited: 12
Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma
Fenglin Dong, Zongzhen Xu, Ying-Qiao Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma
Jialin Wang, Mengxi Xiu, Jin Wang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition
Fangquan Chen, Junhao Lin, Rui Kang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 8, pp. 1515-1527
Closed Access | Times Cited: 8
Perfluorooctanoic Acid Induces Ferroptosis in Hepatocytes via Oxidative Stress and AKT/GSK3β/β-Catenin Pathway Disruption
Feng Yuan, Bin Lü, Yongheng Huang, et al.
ACS Omega (2025)
Open Access | Times Cited: 1
From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma
Zijian Wang, Chunyang Zhou, Yiming Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116074-116074
Open Access | Times Cited: 22
Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma
Jiao Sun, Qi Liu, Yanfang Jiang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
TXNDC12 inhibits lipid peroxidation and ferroptosis
Lanlan Tang, Yan Yu, Wenjun Deng, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108393-108393
Open Access | Times Cited: 14
Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies
Hanyun Zhang, Chunjie Sun, Qi Sun, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 13
Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
Zhili Wu, Yanru Zhu, Wen‐Chao Liu, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 352-352
Open Access | Times Cited: 5
CircTTC13 promotes sorafenib resistance in hepatocellular carcinoma through the inhibition of ferroptosis by targeting the miR-513a-5p/SLC7A11 axis
Ying Zhang, Ruiwei Yao, Mingyi Li, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Exploring the Role of Metabolic Hyperferritinaemia (MHF) in Steatotic Liver Disease (SLD) and Hepatocellular Carcinoma (HCC)
Nikolaos-Andreas Anastasopoulos, Alexandra Barbouti, Anna Goussia, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 842-842
Open Access
The role of non-coding RNA in ferroptosis of liver cancer and its impact on lipid peroxidation
Minglu Ding, Keyuan Huo, Xiaojie Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bibliometric and Graphical Analysis of Ferroptosis and Aging Research: Trends, Gaps, and Future Directions
Siyang Cao, Yingchen Pang, Yihao Wei, et al.
Pathology - Research and Practice (2025), pp. 155949-155949
Closed Access
C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1
Xinyue Sun, Jinge Wu, Heng Lv, et al.
Metabolism (2025), pp. 156242-156242
Closed Access
COPS5 Triggers Ferroptosis Defense by Stabilizing MK2 in Hepatocellular Carcinoma
Aiyun Luo, Wenxin Zheng, Qiong Zhang, et al.
Advanced Science (2025)
Open Access
Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access
Sorafenib-induced macrophage extracellular traps via ARHGDIG/IL4/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma
Xiangbo Huang, Nan Yi, Pengfei Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Differences of ferroptosis-related genes between White and Asian patients with liver cancer.
Xia Pu, Gui-Min Wen, Xiaohui Zheng, et al.
PubMed (2023) Vol. 13, Iss. 8, pp. 3659-3667
Closed Access | Times Cited: 4
Ciprofloxacin is a novel anti-ferroptotic antibiotic
Fangquan Chen, Hu Tang, Junhao Lin, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32571-e32571
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top